Anti-Ranibizumab Polyclonal An

宿主	Rabbit
特异性	The product is specific for Ranibizumab. This antibody serves as an excellent positive control for Ranibizumab immunogenicity (ADA) assays.
经测试应用	ELISA: 1:4000-1:8000
免疫原	Ranibizumab
状态	Liquid
保存溶液	0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
浓度	0.5 mg/ml
克隆类型	Polyclonal
同种型	IgG
应用	ELISA
靶标	Rabbit polyclonal to Lucentis.
纯化方式	Purified by antigen affinity column.
Accession号	CAS: 347396-82-1
稳定性和存储	The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles.
背景	Ranibizumab with trade name Lucentis, is an FDA-approved drug for the treatment of patients with neovascular (Wet) age-related macular degeneration (AMD) and macular edema following retinal vein occlusion (RVO). It is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment. Ranibizumab binds to vascular endothelial growth factor A (VEGF-A) and blocks its activity. Antibodysystem Anti-Ranibizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Ranibizumab.
备注	Antibodysystem can customize this product per customer's request including product size, buffer components, etc. For research use only.

Established in 2019 in France, AntibodySystem Laboratories SAS is a standalone brand dedicated to the production of protein and antibody reagents for life science research. We aim to empower researchers globally with high-quality products for fundamental scientific research. AntibodySystem offers a broad selection, including traditional polyclonal antibodies, essential housekeeping antibodies, tag antibodies, high-potency proteins, functional antibodies for in vivo use, low-background flow antibodies, highly specific nanobodies, unique small molecule antibodies, high-quality phospho-specific antibodies, DNA/RNA antibodies, and PEG antibodies, among others.
AntibodySystem's product range supports research in multiple fields, encompassing 48 types of viruses, superbugs, parasites, oncology, Alzheimer's, Parkinson's, hypersensitivity, immune suppression, and immune activation.